Navigation Links
Retina Specialty Institute Gives Patients Something to Look Forward to in Crestview
Date:1/20/2013

Crestview, FL (PRWEB) January 21, 2013

Retina Specialty Institute is opening a new office location in Crestview, Fla. to help treat patients suffering from Age-Related Macular Degeneration (AMD), Diabetic Retinopathy and other vision-threatening retinal diseases. Retina Specialty Institute is a national, FDA-approved clinical trial study center based out of Pensacola, Fla. with offices in Mississippi, Alabama and the Florida Gulf Coast.

“Many of our patients in the Crestview, Niceville and surrounding area have had to drive to our Pensacola or Fort Walton Beach offices in order to seek treatments,” said Sunil Gupta, M.D., founder of Retina Specialty Institute.

“This new location will offer patients in these areas accessibility to more convenient treatment that will best fit their personal, transportational and scheduling needs.“

The new office, opening January 18, 2013, is located at 1299 Industrial Drive, Crestview, FL 32539. Dr. Gupta, Dr. John Myers and Dr. Ryan Tarantola and their staff are currently accepting new appointments for patients seeking treatments.

For more information regarding the new office location, including office hours and scheduling appointments, call toll-free at 1-855-5RETINA.

Through its mission of preserving, treating and advancing the science of sight, Retina Specialty Institute offers national clinical trials and state-of-the art surgical skills to patients throughout the Southeast including Pensacola, Fla., Mobile, Ala., and Hattiesburg, Miss. For more information, visit http://www.retinaspecialty.com or to schedule an appointment, call 850-476-6759 or toll-free 866-293-8159.

# # #

Read the full story at http://www.prweb.com/releases/2013/1/prweb10335673.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related medicine news :

1. Retinal Device Restores Sight to Blind Mice
2. Study finds novel therapy that may prevent damage to the retina in diabetic eye diseases
3. Prosthetic retina offers simple solution to restoring sight
4. New type of retinal prosthesis could better restore sight to blind, Stanford study says
5. Gene Signal presents data at ARVO 2012 showing topical aganirsen is active in retinal disease
6. Antibiotics Linked to Retinal Detachment Risk
7. Aesthetic Dermatology Specialty Centre Gets A Facelift
8. The JAMA Network announces new names, new embargo schedules for specialty journals
9. Leisure Fitness Opens 23rd Fitness Equipment Super Store in Paramus, NJ, Bringing Specialty Fitness Equipment and Health & Wellness to the New Jersey Fitness Community
10. Health reform: How community health centers could offer better access to subspecialty care
11. Ethics should drive health policy reform, especially with physician-owned specialty hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... Salt Lake City, UT (PRWEB) , ... August 03, 2015 , ... ... announced the release of the T500 cable , a Bluetooth Code Reader accessory ... mobile devices, including iOS products. The T500 helps enable a variety of barcode ...
(Date:8/3/2015)... , ... August 03, 2015 , ... According to an opinion piece published ... person’s diet leads to one pound of weight loss may not be accurate. While this ... translates to one pound of fat varies – based both on the individual and at ...
(Date:8/3/2015)... Los Angeles, California (PRWEB) , ... August 03, ... ... the Fifth Circuit Court of Appeals ruled in favor of the firm’s client ... Act ), North Cypress Medical Center must reimburse benefits for Hamsher’s residential treatment ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... to contract research organisations (CROs) for a slew of benefits, allowing them to ... and operations, boost quality with cost-effective utilisation of resources, get access to innovation ...
(Date:8/3/2015)... ... August 03, 2015 , ... Catalent Pharma Solutions, the ... and consumer health products, today welcomed the announcement by OPKO Health that the ... for a new treatment for chronic kidney disease (CKD) and vitamin D insufficiency, ...
Breaking Medicine News(10 mins):Health News:Code Launches the T500, an Innovative Code Reader Accessory 2Health News:Code Launches the T500, an Innovative Code Reader Accessory 3Health News:Article Dispelling Weight Loss Myth Correctly Emphasizes the Complicated and Difficult Nature of Weight Loss, Says Dr. Michael Feiz 2Health News:Kantor & Kantor Announces North Cypress Medical Center Must Reimburse Benefits for Mental Health Treatment 2Health News:Kantor & Kantor Announces North Cypress Medical Center Must Reimburse Benefits for Mental Health Treatment 3Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 2Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 3Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3
... Maik Behrens, Susann Foerster, Frauke Staehler, Jan-Dirk Raguse, and ... taste receptors are there to protect us from toxins, ... been debated whether we can discriminate between bitter-tasting compounds ... taste is encoded by a family of 25 TAS2 ...
... 13 AMERIGROUP,Corporation (NYSE: AGP ) today announced ... Investor Conference on November 27 in New,York City. ... Tuesday,November 27 at 2:00 p.m. Eastern Time, can be ... investors, page. A replay will be,available for 30 days, ...
... and Funds to Fight Homelessness in Los Angeles ... ANGELES, Nov. 13 United Way of Greater Los ... fight homelessness on,Saturday morning, November 17, 2007, by participating ... Park near downtown Los Angeles.,HomeWalk will engage participants through ...
... has chosen Rita B. Effros of the University of California, ... Kleemeier Award. This distinction is given annually to a GSA ... gerontology. , The award presentation will take place at GSA,s ... 16th - 20th, 2007 in San Francisco, CA. The actual ...
... Society of America (GSA) has chosen Lynn M. Martire ... of the Margret M. & Paul B. Baltes Foundation ... career contributions in behavioral and social gerontology. , The ... Scientific Meeting, which will be held from November 16th ...
... Nov. 13 Green Earth Waterless Carwash, the,only Los ... products and auto detailing services, today announced an agreement,with ... month as part of,the hospital,s employee appreciation program. An ... to the hospital. "We originally signed on for ...
Cached Medicine News:Health News:News Tips from the Journal of Neuroscience 2Health News:News Tips from the Journal of Neuroscience 3Health News:United Way of Greater Los Angeles and Fannie Mae Foundation Announce 3000 Marchers for HomeWalk 2007 2Health News:United Way of Greater Los Angeles and Fannie Mae Foundation Announce 3000 Marchers for HomeWalk 2007 3Health News:Childrens Hospital Los Angeles Turns Off the Tap With Green Earth Waterless Carwash 2
(Date:8/3/2015)... Aug. 3, 2015  Array BioPharma Inc. (NASDAQ: ... fourth quarter and full year of its fiscal ... Squarer, Chief Executive Officer of Array, noted, "Binimetinib and ... are on track for regulatory submissions in 2016. ... melanoma and BRAF-mutant colorectal cancer further validate the ...
(Date:8/3/2015)... FLORHAM PARK, N.J. , Aug. 3, 2015 /PRNewswire/ ... primary and secondary endpoints in a phase III study ... in adult patients with chronic non-cancer pain. Naldemedine is ... This is the third Phase III trial in which ... Study results showed that a 0.2 mg tablet ...
(Date:8/3/2015)... ST. PAUL, Minn. , Aug. 3, 2015 /PRNewswire/ ... devices using neuroblocking therapy to treat obesity, metabolic diseases ... C. McDougal has been appointed to the Board ... serve as a Class II Director until the 2018 ... qualified. Ms. McDougal has served in an ...
Breaking Medicine Technology:Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 10Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 11Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 12Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 4EnteroMedics Announces Appointment of Lori C. McDougal to the Board of Directors 2EnteroMedics Announces Appointment of Lori C. McDougal to the Board of Directors 3
... of Novel Proteasome Inhibitor in ... Patients with Relapsed Solid Tumors, SOUTH SAN ... South Texas Accelerated Research Therapeutics (START),today announced the enrollment of ... Proteolix,s investigational drug, carfilzomib (PR-171).,START is participating in the study ...
... Protects the Ocular Surface Following Exposure to ... Dry Eye Symptoms, LAGUNA HILLS, Calif., Oct. 9 ... ALTY-0501, demonstrated statistically,significant advantages over vehicle in its ability ... Phase 2 study. The Phase 2 study utilized ...
Cached Medicine Technology:Proteolix Initiates Multicenter Open-label Study of the Safety and Activity of Carfilzomib in Subjects With Relapsed Solid Tumors 2Proteolix Initiates Multicenter Open-label Study of the Safety and Activity of Carfilzomib in Subjects With Relapsed Solid Tumors 3Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501 2Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501 3
96 well format, Gradient features tests 12 PCR annealing temperatures in 1 run...
... Family offers fast temperature control, exact block ... Personal cards enable safe program storage as ... individual protocols between different Mastercyclers. All models ... come with a two-year warranty. The ...
... 96 well thermocycler with ... Peltier technology for fastest available ... to 4C/sec with High Pressure ... PCR plates. Includes motorized ...
... graphical touch screen display which enables you ... of a screen." Features & Benefits ... Graphical Display, Memory Cards, Gradient Calculator, Fold ... Programmin, Free Instrument Software Upgrade. Includes ...
Medicine Products: